Regulus has appointed William Rastetter to its board of directors. Rastetter is currently chairman of the board of Illumina, Fate Therapeutics, Neurocrine Biosciences, and Receptos. He holds a PhD and MA in chemistry from Harvard University.
Onconova has appointed Ajay Bansal chief financial officer. Bansal most recently served as chief financial officer for Complete Genomics. He has also served as chief financial officer and executive vice president of corporate and business development for Lexicon Therapeutics and Tercica. He has also worked in strategy and marketing for Novartis Pharmaceuticals and held positions at consulting firms such as McKinsey & Company. He holds master's degrees in management and operations research from Northwestern University.